Trial Profile
Phase II Clinical Study of Capecitabine in Combination With Mitomycin C as First-Line Treatment in Patients With Metastatic Breast Cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Mitomycin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 16 Sep 2010 New trial record